The Toltrazuril Solution: How VETR.com Is Tackling Coccidia with Speed and Scale

- Share via
In a fragmented and increasingly digitalized pet care market, one company is bridging the divide between innovation and the essential human element of veterinary medicine. VETR.com, founded by entrepreneur Andrew Hamilton, is rapidly emerging as a disruptor with a conscience – blending cutting-edge technology, scalable logistics and an unprecedented model of professional collaboration aimed at redefining how animals receive care in the United States.
From the outside, VETR.com may resemble a telehealth startup or a veterinary eCommerce platform. But beneath the surface, it is something far more sophisticated: a vertically integrated pet health ecosystem, designed to improve treatment access while reinforcing – not replacing – the role of veterinary professionals.
Now, the company is taking its mission a step further with the launch of an ambitious affiliate program, offering veterinarians and animal health providers up to 20% per sale on medications they recommend through the platform. The result is a business model that doesn’t just scale access, it shares value.
A System Built on Personal Loss
Hamilton’s journey to founding VETR wasn’t academic. It was personal. In 2021, while on vacation with his family, his 11-year-old Great Dane became critically ill at a boarding facility. Local veterinary clinics were overwhelmed, and the only available solution was an emergency euthanasia, conducted over a Zoom call. Despite spending over $5,000, the outcome was heartbreaking.
That moment underscored the fragility of the pet healthcare system: a lack of 24/7 access, severe staff shortages and logistical hurdles that prevent timely treatment.
“I realized there was a massive gap between need and access and that technology alone wasn’t going to fix it unless we included veterinarians in the solution,” Hamilton says.
Out of that realization came VETR.com, a platform that is working to provide on-demand virtual veterinary consultations, AI-supported treatment recommendations and direct-to-consumer delivery of both prescription and over-the-counter pet medications. And it’s not stopping there.
Creating Economic Incentives for Vets
Unlike many pet health startups that lean on automation to reduce human involvement, VETR is investing in the professional infrastructure of the industry. Its affiliate program allows clinics, independent veterinarians, breeders and shelters to integrate VETR services and products into their workflow, earning a percentage of each sale they help drive.
For veterinarians who opt into teleconsultation services on the platform, the system includes AI-generated treatment recommendations – powered by case analysis and pattern recognition – to streamline diagnostics and provide backup support during busy hours or emergency calls. All final treatment decisions remain in the hands of the licensed veterinarian, ensuring clinical oversight is never compromised.
This approach doesn’t just create convenience; it generates new, passive income for an industry often strained by thin margins and burnout.
Manufacturing Control and Speed to Treatment
One of VETR’s core differentiators lies in its supply chain. The company is the largest registered U.S. manufacturer of toltrazuril, a medication widely used to treat coccidiosis, a highly contagious parasitic infection common in puppies and kittens. For years, access to toltrazuril has been inconsistent in the U.S., forcing veterinarians to source internationally or face frequent backorders. Today, Vetr.com offers two-day shipping of ToltraMax, its high-quality, in-house formulation of toltrazuril, ensuring fast, reliable access for breeders, shelters and veterinary clinics nationwide.
By controlling its own production pipeline, VETR ensures that essential medications are available on demand, with two-day and in some cases same-day shipping to consumers and clinics across the country. This logistics advantage is particularly impactful for rural and underserved communities, where veterinary infrastructure is limited.
“One of the most overlooked aspects of pet health is logistics,” Hamilton says. “It doesn’t matter how skilled a vet is if the medication they need is out of stock or a week away. That’s a systemic failure we aim to solve.”
From WooCommerce to Shopify: Plug-In Innovation
VETR’s expansion into tech-enabled commerce includes a WooCommerce plugin, allowing veterinary clinics, breeders and rescue organizations to integrate VETR’s catalog directly into their websites. The company plans to roll out a Shopify-compatible version later this year, further expanding access to thousands of small and medium-sized animal care providers who want to offer vetted medications directly to their communities.
This is more than convenience. It’s infrastructure. It allows trusted animal professionals to retain the relationship with their clients, support medication adherence and monetize the care journey without being cut out by online pharmacies.
A Mission Grounded in Equity, Access, and Collaboration
What sets VETR apart isn’t just its technology stack or even its pharmaceutical capabilities – it’s its philosophical approach. In an industry that’s often been pushed toward commoditization, VETR is staking its claim on partnership. By ensuring that veterinarians benefit financially from the digital shift, it’s addressing one of the most pressing concerns in modern veterinary care: sustainability.
With pet ownership at an all-time high and the demand for veterinary services skyrocketing, solutions like VETR’s represent a necessary evolution – one that expands access without eroding trust.
Veterinarians and pet health professionals interested in joining the affiliate or kickback program can visit www.vetr.com/partners to learn more.
In a world of venture-backed health startups and app-based quick fixes, VETR.com is building something different – something lasting. A platform that doesn’t just serve animals but strengthens the ecosystem designed to protect them. And in doing so, it may just be giving veterinary medicine the upgrade it deserves.